{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BLAST&page=2", "query": { "intervention": "BLAST", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=BLAST&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-08T05:11:29.643Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00072475", "title": "Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms" ], "interventions": [ { "name": "vatalanib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2003-12", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2016-08-01", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 68, "location_summary": "Lewes, Delaware • Newark, Delaware • Fort Lauderdale, Florida + 50 more", "locations": [ { "city": "Lewes", "state": "Delaware" }, { "city": "Newark", "state": "Delaware" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Jupiter", "state": "Florida" }, { "city": "Miami Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00072475" }, { "nct_id": "NCT07606651", "title": "Blast Overpressure Longitudinal Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Low-level Blast Exposure" ], "interventions": [], "intervention_types": [], "sponsor": "Uniformed Services University of the Health Sciences", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 250, "start_date": "2026-05", "completion_date": "2030-08", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 3, "location_summary": "Bethesda, Maryland • Fort Bragg, North Carolina • San Antonio, Texas", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Fort Bragg", "state": "North Carolina" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07606651" }, { "nct_id": "NCT07071350", "title": "Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Autonomic Nervous System Disease", "Concussive Injury", "Mild Traumatic Brain Injury", "Post Traumatic Stress Disorder", "Persistent Post Concussion Syndrome" ], "interventions": [ { "name": "HRV Coherence Ratio", "type": "OTHER" }, { "name": "NSI", "type": "BEHAVIORAL" }, { "name": "Pittsburgh Sleep Quality Index (PSQI)", "type": "BEHAVIORAL" }, { "name": "Quantitative Sleep Measures", "type": "BEHAVIORAL" }, { "name": "Patient Global Impression of Change (PGIC)", "type": "BEHAVIORAL" }, { "name": "Cognitive Performance/NIH Toolbox Cognitive Battery", "type": "BEHAVIORAL" }, { "name": "Pain Interference/TBI-QoL Pain Interference Short-Form", "type": "OTHER" }, { "name": "Patient Health Questionnaire-9 (PHQ-9)", "type": "BEHAVIORAL" }, { "name": "PTSD Checklist for DSM-5 (PCL-5)", "type": "BEHAVIORAL" }, { "name": "HRV Biofeedback (HRV-B)", "type": "OTHER" }, { "name": "Psychoeducational (Edu) Comparator Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "Virginia Commonwealth University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 148, "start_date": "2025-09-02", "completion_date": "2028-09", "has_results": false, "last_update_posted_date": "2025-09-17", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 1, "location_summary": "Richmond, Virginia", "locations": [ { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07071350" }, { "nct_id": "NCT00004047", "title": "Chemotherapy in Treating Patients Who Have Hematologic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Leukemia", "Myelodysplastic Syndromes" ], "interventions": [ { "name": "exatecan mesylate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Daiichi Sankyo", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": "1999-06", "completion_date": "2005-04", "has_results": false, "last_update_posted_date": "2012-05-16", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004047" }, { "nct_id": "NCT00003335", "title": "Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Versus Host Disease", "Leukemia", "Lymphoma", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Diseases" ], "interventions": [ { "name": "anti-thymocyte globulin", "type": "BIOLOGICAL" }, { "name": "busulfan", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "umbilical cord blood transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Case Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "54 Years", "sex": "ALL", "summary": "Up to 54 Years" }, "enrollment_count": 44, "start_date": "1998-01", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2012-03-15", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003335" }, { "nct_id": "NCT01004640", "title": "Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukemia" ], "interventions": [ { "name": "DNA analysis", "type": "GENETIC" }, { "name": "Southern blotting", "type": "GENETIC" }, { "name": "cytogenetic analysis", "type": "GENETIC" }, { "name": "polymerase chain reaction", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 60, "start_date": "1998-12-15", "completion_date": null, "has_results": false, "last_update_posted_date": "2023-09-14", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 161, "location_summary": "San Diego, California • San Francisco, California • Lewes, Delaware + 89 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Lewes", "state": "Delaware" }, { "city": "Newark", "state": "Delaware" }, { "city": "Seaford", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT01004640" }, { "nct_id": "NCT00171158", "title": "An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Participants With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Blast Crisis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Philadelphia Chromosome Positive CML" ], "interventions": [ { "name": "imatinib mesylate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 260, "start_date": "1999-07-26", "completion_date": "2013-04-22", "has_results": true, "last_update_posted_date": "2021-06-25", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 3, "location_summary": "Chicago, Illinois • Boston, Massachusetts • Houston, Texas", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00171158" }, { "nct_id": "NCT00997243", "title": "Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Leukemia", "Myelodysplastic Syndromes" ], "interventions": [ { "name": "lintuzumab", "type": "BIOLOGICAL" }, { "name": "5-azacytidine", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Alison Walker", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 7, "start_date": "2009-11", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2017-05-10", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00997243" }, { "nct_id": "NCT05600894", "title": "Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Myelomonocytic Leukemia", "Myelodysplastic Syndrome", "Myelodysplastic Syndrome With Excess Blasts", "Myelodysplastic/Myeloproliferative Neoplasm", "Myeloproliferative Neoplasm" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Decitabine and Cedazuridine", "type": "DRUG" }, { "name": "Venetoclax", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2023-06-27", "completion_date": "2027-08-31", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 33, "location_summary": "Phoenix, Arizona • Costa Mesa, California • Irvine, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05600894" }, { "nct_id": "NCT00038051", "title": "Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Myeloproliferative Disorders", "Anemia, Refractory, With Excess of Blasts" ], "interventions": [ { "name": "Hum-195/rGel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "1999-05", "completion_date": "2013-02", "has_results": false, "last_update_posted_date": "2013-04-04", "last_synced_at": "2026-09-08T05:11:29.643Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00038051" } ] }